3D Bioprinting Market is forecasted to value over USD 2.4 billion by 2028 end and register a CAGR of 20% from the forecast period 2021-2028.

The material science sector has witnessed a significant boom in recent years owing to the introduction of additive manufacturing i.e. 3D printing, which provides the freedom of experimenting with newer materials that can optimize the overall product efficiency and functionality. With the assistance of AI, the additive manufacturing sector shall boost its search for newer materials in the upcoming years, thus assisting in the overall growth of the industry. Moreover, 3D printing helps in establishing micro-factories that are economically efficient, transforming the global supply chain ecosystem, and in strengthening local networks. Additionally, the 3D printers shall receive some instrumental updates which shall increase the speed of printing, so much so that it would be able to print faster than a conventional 2D printer.

The 3D Bioprinting Market is assessed based on factors such as competitive analysis of the progress of emerging players and new entrants, the business expansion policies of key players, the financial and opportunity analysis of market players. Furthermore, the 3D Bioprinting Market is analyzed for the product type or technique, regional segmentation, end-user spectrum, etc. This research will be conducted with the implementation of the latest market research methodologies which shall help organizations understand the overall market scenario and strategize accordingly.

Major players included in the 3D Bioprinting Market:

  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Nano3D Biosciences, Inc.
  • Organovo Holdings, Inc.
  • Poietis
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Tevido Biodevices

(Note: The list of the major players will be updated with the latest market scenario and trends)

3D Bioprinting Market Segmentation:
By Component

  • 3D Bioprinters
    • 3D Bioprinters Market, By Technology
      • Microextrusion Bioprinting
      • Inkjet 3D Bioprinting
      • Laser-Assisted Bioprinting
      • Magnetic 3D Bioprinting
      • Other Technologies
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks

By Material

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Biomaterials

By Application

  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Applications
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other Clinical Applications

By End User

  • Research Organizations & Academic Institutes
  • Biopharmaceutical Companies
  • Hospitals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

3D Bioprinting Market Competitive Analysis:

  • Tier-1 Players
  • Tier-2 Players
  • Emerging Players
  • New Entrants

Future Market Analytics Focus Points:

  • SWOT Analysis
  • Key Market Trends
  • Key Data -Points Affecting Market Growth
  • Revenue and Forecast Analysis
  • Growth Opportunities For New Entrants and Emerging Players
  • Key Player and Market Growth Matrix

Objectives of the Study:

  • To provide a comprehensive analysis on the 3D Bioprinting Market by component, by material, by application, by end user and by region
  • To cater extensive insights on factors influencing the market growth (drivers, restraints, industry-specific restraints, business expansion opportunities)
  • To anticipate and analyse the market size expansion in key regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- strategic alliances and mergers, technological advancements and product launches, revenue and financial analysis of key market players

 
In case of any requirements or changes to the current table of content please contact us at:enquiry@futuremarketanalytics.com

Description

1. Market Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Market Scope
         1.3.1 Years Considered for the Study
         1.3.2 Market Covered
    1.4. Currency
    1.5. Limitations
    1.6. Stakeholders

2. Research Methodology
    2.1. Research Data
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation
    2.3. Market Breakdown and Data Triangulation
    2.4. Assumptions for the Study

3. Executive Summary
    3.1. Market Outlook
    3.2. Segment Outlook
    3.3. Competitive Insights

4. Market Variables, Trends & Scope
    4.1. Market Lineage Outlook
    4.2. Penetration and Growth Prospect Mapping
    4.3. Industry Value Chain Analysis
    4.4. Cost Analysis Breakdown
    4.5. Technology Overview
    4.6. Regulatory Framework on Country Level
         4.6.1. Reimbursement Framework
         4.6.2. Standards and Compliances

5. Market Overview
    5.1. Market Dynamics
         5.1.1. Market Driver Analysis
         5.1.2. Market Restraint Analysis
         5.1.3. Industry Challenges

6. Market Analysis Tools
    6.1. Industry Analysis – Porter’s
         6.1.1. Supplier Power
         6.1.2. Buyer Power
         6.1.3. Substitution Threat
         6.1.4. Threat from new entrants
         6.1.5. Competitive Rivalry
    6.2. Pestel Analysis
         6.2.1. Political Landscape
         6.2.2. Environmental Landscape
         6.2.3. Social landscape
         6.2.4. Technology landscape
         6.2.5. Legal Landscape

7. 3D Bioprinting Market, By Component Historical Analysis 2016 to 2020 and Forecast 2021-2028 (USD million)
    7.1. 3D Bioprinters
         7.1.1. 3D Bioprinters Market, By Technology
                7.1.1.1. Microextrusion Bioprinting
                7.1.1.2. Inkjet 3D Bioprinting
                7.1.1.3. Laser-Assisted Bioprinting
                7.1.1.4. Magnetic 3D Bioprinting
                7.1.1.5. Other Technologies
    7.2. Bioinks
         7.2.1. Natural Bioinks
         7.2.2. Hybrid Bioinks
         7.2.3. Synthetic Bioinks

8. 3D Bioprinting Market, By Material Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    8.1. Hydrogel
    8.2. Living Cells
    8.3. Extracellular Matrices
    8.4. Other Biomaterials

9. 3D Bioprinting Market, By Application Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    9.1. Research Applications
         9.1.1. Drug Research
         9.1.2. Regenerative Medicine
         9.1.3. 3D Cell Culture
    9.2. Clinical Applications
         9.2.1. Skin
         9.2.2. Bone & Cartilage
         9.2.3. Blood Vessels
         9.2.4. Other Clinical Applications

10. 3D Bioprinting Market, By End User Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    10.1. Research Organizations & Academic Institutes
    10.2. Biopharmaceutical Companies
    10.3. Hospitals

11. North America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         11.2.1. U.S.
         11.2.2. Canada
         11.2.3. Mexico
         11.2.4. Rest of North America
    11.3. Market Size (USD Mn) Forecast for North America 2021-2028

12. Latin America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    12.1. Introduction
    12.2. Regional Market Trends
    12.3. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         12.3.1. Brazil
         12.3.2. Venezuela
         12.3.2. Argentina
         12.3.3. Rest of Latin America
    12.4 Market Size (USD Mn) Forecast for Latin America 2021-2028

13. Europe Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         13.2.1. Germany
         13.2.2. U.K
         13.2.3. France
         13.2.4. Italy
         13.2.5. Switzerland
         13.2.6. Spain
         13.2.7. Russia
         13.2.8. Poland
         13.2.9. Rest of Europe
    13.3. Market Size (USD Mn) Forecast for Europe 2021-2028

14. Asia Pacific Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         14.2.1. Japan
         14.2.2. China
         14.2.3. Singapore
         14.2.4. Korea
         14.2.5. India
         14.2.6. Australia and New Zealand
         14.2.7. ASEAN
         14.2.8. Rest of Asia Pacific
    14.3. Market Size (USD Mn) Forecast for Asia Pacific 2021-2028

15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         15.2.1. UAE
         15.2.2. South Africa
         15.2.3. Egypt
         15.2.4. Saudi Arabia
         15.2.5. Rest of MEA
    15.3. Market Size (USD Mn) Forecast for MEA 2021-2028

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    16.1. Advanced Solutions Life Sciences
         16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
    16.2. Allevi Inc
         16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
    16.3. Aspect Biosystems Ltd
         16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
    16.4. Cellink
         16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
    16.5. Cyfuse Biomedical K.K.
         16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview
    16.6. Digilab, Inc.
         16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview
    16.7. Envisiontec
         16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
    16.8. Gesim
         16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
    16.9. Nano3D Biosciences, Inc
         16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
    16.10. Organovo Holdings, Inc.
         16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
    16.11. Poietis
         16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview
    16.12. Regenhu
         16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.12.2. Product Portfolio
         16.12.3. SWOT Analysis
         16.12.4. Financial Overview
         16.12.5. Strategic Overview
    16.13. Regenovo Biotechnology Co., Ltd.
         16.13.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.13.2. Product Portfolio
         16.13.3. SWOT Analysis
         16.13.4. Financial Overview
         16.13.5. Strategic Overview
    16.14. Rokit Healthcare
         16.14.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.14.2. Product Portfolio
         16.14.3. SWOT Analysis
         16.14.4. Financial Overview
         16.14.5. Strategic Overview
    16.15. Tevido Biodevices
         16.15.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.15.2. Product Portfolio
         16.15.3. SWOT Analysis
         16.15.4. Financial Overview
         16.15.5. Strategic Overview

17. Impact of COVID-19
    17.1. Positive influence on the industry
    17.2. The financial disruption of the sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the industry regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. Competitive Intelligence and Competitive Matrix
    18.1. Competitive Intelligence
    18.2. Competitive Matrix

19. Major Deals and Strategic Alliances Analysis
    19.1. Joint ventures
    19.2. Mergers and acquisitions
    19.3. Licensing and partnerships
    19.4. Technology Collaborations
    19.5. Strategic Divestments
    19.6. Market Entry Strategies

20. Relevant Case Studies and Latest News Updates

21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics